Over the course of the past month investors have not been particularly kind to the AnPac Bio-Medical Science Co Ltd (NASDAQ:ANPC) stock and that has become apparent in the price action. During that period, the stock has tanked by as much as 38% and it is perhaps a good time for investors to figure out if it might actually be an opportunity.
Trading Data
On Friday, ANPC stock moved down 3% at $1.70 with more than 641K shares, compared to its average volume of 204K shares. The stock has moved within a range of $ 1.6800 – 1.8000 after opening trading at $1.742.
Earnings Recap
As it happens, the company was in the news yesterday after it announced is unaudited financial results for the first nine months of the year that had ended on September 30, 2021. It should be noted that the numbers might differ once the company’s independent auditor goes through the numbers.
AnPac Bio-Medical managed to bring in revenues of as much as RMB13.7 million in the first nine months of the year and that reflected a year on year rise of as much as 55.3% from the RMB8.8 million that it had generated in the prior year period. However, that was not the only highlight. In the first nine months, the Chinese firm had also managed to generate gross margin of as much as 59.3%. That reflected a rise of as much as 8.8% on a year on year basis.
Technical Data
ANPC stock is trading below the 20-Day and 50-Day Moving averages of $2 and $2.66 respectively. Moreover, the stock is trading below the 200-Day moving average of $4.29. The stock is down 38% in the past month.
